Restart Life Sciences Corp. (CSE:HEAL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
0.00 (0.00%)
May 28, 2025, 4:00 PM EDT
-60.00%
Market Cap 2.02M
Revenue (ttm) n/a
Net Income (ttm) -449.63K
Shares Out 33.73M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,780
Average Volume 40,158
Open 0.0600
Previous Close 0.0600
Day's Range 0.0600 - 0.0600
52-Week Range 0.0300 - 0.2000
Beta -0.42
RSI 45.47
Earnings Date May 27, 2025

About Restart Life Sciences

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol HEAL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.